Subtypes


Web

  • http://rarediseases.org/rare-diseases/multiple-myeloma/
  • Multiple myeloma is a rare form of cancer (1% of malignancy) characterized by excessive production (proliferation) and improper function of certain cells (plasma cells) found in the bone marrow.
  • http://healthinfo.uclahealth.org/Library/DiseasesConditions/Adult...
  • Q: What is multiple myeloma?A: Multiple myeloma is a kind of cancer that begins in plasma cells, a type of white blood cell.
  • http://www.merckmanuals.com/professional/hematology-and-oncology/...
  • Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue.
  • http://www.pennmedicine.org/encyclopedia/em_DisplayArticle.aspx?g...
  • Multiple myeloma is a blood cancer that starts in the plasma cells in the bone marrow.
  • http://orthoinfo.aaos.org/topic.cfm?topic=A00086
  • Multiple myeloma is the most common primary bone cancer.It accounts for 1% of all cancers.
  • http://familydoctor.org/familydoctor/en/diseases-conditions/multi...
  • The symptoms of multiple myeloma include:
  • http://www.uoflphysicians.com/health-information/health-library?p...
  • Multiple myeloma is cancer that starts in the plasma cells in bone marrow.
  • http://www.aafp.org/afp/1999/0401/p1885.html
  • Multiple myeloma is the malignant proliferation of plasma cells involving more than 10 percent of the bone marrow.
  • http://www.uptodate.com/contents/multiple-myeloma-treatment-beyon...
  • The treatment of multiple myeloma (MM) is complex because of rapid advances in stem cell transplantation, medications, and better supportive care, which have led to improved survival for patients with multiple myeloma over the past 30 years [1]....
  • http://www.cancervic.org.au/about-cancer/cancer_types/multiple_my...
  • Multiple myeloma can be treated by chemotherapy, steroids, radiotherapy, thalidomide or thalidomide-related drugs, bortezomib and immunotherapy.
  • 1 2 3 4 5 6 7 8 9

    News

    FDA approves new treatment for refractory multiple myeloma
    U.S. Food and Drug Administration - Friday, July 12, 2019
    Cardiac Toxicity Risk Factors Identified With Relapsed Multiple Myeloma Therapy
    Science Daily - Thursday, June 27, 2019
    Prospective target assessment and multimodal prediction of survival for personalized and risk - adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial
    Jho Online - Thursday, June 27, 2019
    Private Insurance, Higher Regional Incomes, and Certain Practice Settings Predict Longer Survival for People With Multiple Myeloma
    American Society of Clinical Oncology - Tuesday, June 11, 2019
    The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
    Nature - Sunday, May 26, 2019
    Lenalidomide Reduces Risk That Precancer Myeloma Will Progress to Overt Multiple Myeloma in High Risk Individuals
    American Society of Clinical Oncology - Sunday, May 26, 2019
    CAR T-Cell Therapy Safe and Active in Advanced Multiple Myeloma
    Medpagetoday - Saturday, May 11, 2019
    CAR T-Cell Therapy Emerges in Multiple Myeloma
    Medpage Today - Monday, May 6, 2019
    Multiple myeloma: DNA rearrangement may predict poor outcomes
    Science Daily - Saturday, April 27, 2019
    Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
    Nature - Saturday, April 27, 2019
    Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells
    Nature - Saturday, April 27, 2019
    Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma
    Nature - Sunday, April 14, 2019
    Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
    Nature - Sunday, April 14, 2019
    Multiple Myeloma, May 20
    Education - Thursday, April 4, 2019
    FDA: Higher Risk for Death Found With Venclexta in Multiple Myeloma
    Physicians Briefing - Monday, March 25, 2019
    Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
    Jho Online - Monday, March 25, 2019
    FDA Warns about the risks associated with the investigational use of Venclexta in Multiple Myeloma
    U.S. Food and Drug Administration - Monday, March 25, 2019
    Recommendations Issued for HSCT in Multiple Myeloma
    Physicians Briefing - Wednesday, March 20, 2019
    MORE NEWS

    Videos

    A New Multiple Myeloma Treatment
         
    http://www.rxwiki.com/news-article/empliciti-elotuzumab-fda-approved-treat-multiple-myeloma-patients-who-have-received Another treatment for multiple myeloma just got an OK from the FDA. Today, the US Food and Drug Administration (FDA) approved Empl...

    New treatments for multiple myeloma - Mayo Clinic
         
    Multiple myeloma is a type of blood cancer involving a certain type of white blood cells that make antibodies, which help the body fight off infection. In this video, Mayo Clinic hematologist Dr. Shaji Kumar talks about the advances in treatment that have...

    Ken Anderson, M.D. highlights the Multiple Myeloma Genomics Initiative's research
         
    The Multiple Myeloma Research Foundation (MMRF) is working with patients, clinicians, and researchers to speed the development of targeted treatments for multiple myeloma. Watch this video of Ken Anderson, M.D., Dana-Farber Cancer Institute and Multiple M...

    Innovations in Multiple Myeloma: The Patient Experience
         
    The treatment options for Multiple Myeloma have greatly evolved over the last decade. How does this affect the patient experience? Patients discuss their personal experiences with their diagnoses of Multiple Myeloma, and the various medical management tec...

    Multiple Advances in Multiple Myeloma
         
    Sagar Lonial, MD, reviews the recent advances in the treatment of multiple myeloma, including how to sequence the newly approved myeloma drugs and their potential for use in combination therapy.

    Treatment Goals in Newly Diagnosed Multiple Myeloma
         
    Rafael Fonseca, MD; Jatin J. Shah, MD; Noopur Raje, MD; Heather J. Landau, MD; and Morie A. Gertz, MD, review various approaches to induction therapy and front-line therapy in newly-diagnosed multiple myeloma.

    Newly Diagnosed Multiple Myeloma
         
    Recorded at Tufts Medical Center on 10/2/15. Dr. Raymond Comenzo talks about newly diagnosed multiple myeloma: what you can expect, what needs to be done, and resources to help you through the process.

    Multiple Myeloma: Diagnosis and Treatment
         
    Dr. Shaji Kumar, a Professor of Medicine in the Division of Hematology at Mayo Clinic in Rochester, MN, gives an update in the January 2016 issue of Mayo Clinic Proceedings for patients with multiple myeloma. He notes that clinicians have a better underst...

    Mambo for Myeloma ~ HOPE - The Philadelphia Multiple Myeloma Networking Group Mambos for Myeloma
         
    HOPE - The Philadelphia Multiple Myeloma Networking Group Mambos for Myeloma during Multiple Myeloma Awareness Month ~ March 14, 2015 OUR MISSION ~ Philadelphia Multiple Myeloma Networking Group’s (PMMNG) mission is to be an ongoing resource for mye...

    Multiple Myeloma Symposium: Bone Health ; Dana-Farber Cancer Institute
         
    Noopur Raje, MD, director of the multiple myeloma program at Massachusetts General Hospital, discusses bone health and multiple myeloma treatment. This presentation was originally given at the Multiple Myeloma Patient Education Symposium on Dec. 13, 2014 ...

    1 2 3 4 5 6 7 8 9

    Images

    Multiple Myeloma
    Multiple Myeloma - Spanish
    NCCN Guidelines for Patients®
    If you have multiple myeloma or are close to someone who does, knowing what to expect can help you cope.
    Treating multiple myeloma
    Multiple Myeloma
    cancer.gov
    Multiple Myeloma - Spanish
    cancer.gov
    NCCN Guidelines for Patients(R)
    nccn.org
    If you have multiple myeloma or are close to someone who does, knowing what to expect can help you cope.
    cancer.org
    Treating multiple myeloma
    mayoclinic.org
    Read more about multiple myeloma, the side-effects and treatment options.
    Bone marrow angiogenesis in multiple myeloma
    Cryoglobulinemia is caused by an abnormal protein that is occasionally found in the blood of people with multiple myeloma, leukemia, and certain forms of pneumonia.
    220px Monoclonal gammopathy Multiple Myeloma
    Role of bone marrow stromal cells in multiple myeloma
    Read more about multiple myeloma, the side-effects and treatment options.
    cancer.ie
    Bone marrow angiogenesis in multiple myeloma
    clevelandclinicmeded.com
    Cryoglobulinemia is caused by an abnormal protein that is occasionally found in the blood of people with multiple myeloma, leukemia, and certain forms of pneumonia.
    drugs.com
    220px Monoclonal gammopathy Multiple Myeloma
    en.wikipedia.org
    Role of bone marrow stromal cells in multiple myeloma
    clevelandclinicmeded.com
    The 21st century has seen great strides in treatment for multiple myeloma, a cancer of the bone marrow.
    File:Lymphomas, multiple myeloma world map - Death - WHO2004.svg
    120px Lymphomas C multiple myeloma world map   Death   WHO2004 svg
    Chemical structure of bortezomib (Boronated form of MG132), a proteasome inhibitor used in chemotherapy that is particularly effective against multiple myeloma
    250px Lymphomas C multiple myeloma world map   Death   WHO2004 svg
    The 21st century has seen great strides in treatment for multiple myeloma, a cancer of the bone marrow.
    dana-farber.org
    File:Lymphomas, multiple myeloma world map - Death - WHO2004.svg
    en.wikipedia.org
    120px Lymphomas C multiple myeloma world map Death WHO2004 svg
    en.wikipedia.org
    Chemical structure of bortezomib (Boronated form of MG132), a proteasome inhibitor used in chemotherapy that is particularly effective against multiple myeloma
    en.wikipedia.org
    250px Lymphomas C multiple myeloma world map Death WHO2004 svg
    en.wikipedia.org
    Micrograph of a plasmacytoma, the histologic correlate of multiple myeloma.
    220px Blausen 0656 Multiple Myeloma
    120px Multiple myeloma    HE stain
    220px Lymphomas C multiple myeloma world map   Death   WHO2004 svg
    Multiple myeloma
    Micrograph of a plasmacytoma, the histologic correlate of multiple myeloma.
    en.wikipedia.org
    220px Blausen 0656 Multiple Myeloma
    en.wikipedia.org
    120px Multiple myeloma HE stain
    en.wikipedia.org
    220px Lymphomas C multiple myeloma world map Death WHO2004 svg
    en.wikipedia.org
    Multiple myeloma
    ncbi.nlm.nih.gov
    Multiple Myeloma: Bone Lesions, Damage, and Pain
    Stage 3 Multiple Myeloma: Outlook & Treatments
    Diet Tips for Multiple Myeloma
    194x 105 Multiple Myeloma Diagnosis and Next Steps
    The Link Between Multiple Myeloma and Kidney Failure
    Multiple Myeloma: Bone Lesions, Damage, and Pain
    healthline.com
    Stage 3 Multiple Myeloma: Outlook & Treatments
    healthline.com
    Diet Tips for Multiple Myeloma
    healthline.com
    194x 105 Multiple Myeloma Diagnosis and Next Steps
    healthline.com
    The Link Between Multiple Myeloma and Kidney Failure
    healthline.com
    Symptoms & Signs of Multiple Myeloma
    Q: What is multiple myeloma?
    Could weight gain increase your risk for multiple myeloma?
    Multiple Myeloma
    multiple myeloma case study 2
    Symptoms & Signs of Multiple Myeloma
    healthline.com
    Q: What is multiple myeloma?
    uclahealth.org
    Could weight gain increase your risk for multiple myeloma?
    medicinenet.com
    Multiple Myeloma
    medicinenet.com
    multiple myeloma case study 2
    dana-farber.org
    multiple myeloma case study 1
    Multiple myeloma risk factors
    Multiple myeloma symptoms
    Multiple Myeloma
    Types of multiple myeloma
    multiple myeloma case study 1
    dana-farber.org
    Multiple myeloma risk factors
    cancercenter.com
    Multiple myeloma symptoms
    cancercenter.com
    Multiple Myeloma
    nebraskamed.com
    Types of multiple myeloma
    cancercenter.com
    Diagnosing and Treating Smoldering Multiple Myeloma
    Measuring Response to Treatment in Multiple Myeloma
    Three-Year Data Reinforce Benefit of Empliciti in Multiple Myeloma
    Oncologists like Alexander Lesokhin (left) are advancing promising new treatments that can benefit many people with multiple myeloma.
    (May 9, 2012 - Insidermedicine) Taking lenalidomide, a medication popularly known as Revlimid, can help stave off the progression of multiple myeloma following a stem cell transplantation, according to research published in the New England Journal of Medi
    Diagnosing and Treating Smoldering Multiple Myeloma
    curetoday.com
    Measuring Response to Treatment in Multiple Myeloma
    curetoday.com
    Three-Year Data Reinforce Benefit of Empliciti in Multiple Myeloma
    curetoday.com
    Oncologists like Alexander Lesokhin (left) are advancing promising new treatments that can benefit many people with multiple myeloma.
    mskcc.org
    (May 9, 2012 - Insidermedicine) Taking lenalidomide, a medication popularly known as Revlimid, can help stave off the progression of multiple myeloma following a stem cell transplantation, according to research published in the New England Journal of Medi
    insidermedicine.com

    MORE IMAGES